This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.
We are delighted to announce that the 2016 award will be presented to Professor Sir Michael Stratton of the Wellcome Trust Sanger Institute, UK. Professor Stratton will receive the Mike Price Gold Medal and deliver the closing lecture at EACR-24 in (Manchester, UK, 9-12 July 2016).
About the Winner: Professor Sir Michael Stratton
Mike Stratton is Director of the Wellcome Trust Sanger Institute. His primary research interests have been in the genetics of cancer. His early research focused on inherited susceptibility. He mapped and identified the major high risk breast cancer susceptibility gene BRCA2 and subsequently a series of moderate risk breast cancer and other cancer susceptibility genes.
In 2000 he initiated the Cancer Genome Project at the Wellcome Trust Sanger Institute which conducts systematic genome-wide searches for somatic mutations in human cancer. Through these studies he discovered somatic mutations of the BRAF gene in malignant melanoma and several other mutated cancer genes in lung, renal, breast and other cancers. He has described the basic patterns of somatic mutation in cancer genomes revealing underlying DNA mutational and repair processes.
He is a Fellow of the Royal Society (FRS) and was Knighted by the Queen in 2013.